Laddar...
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
BACKGROUND. The use of gemcitabine as an adjuvant modality for cholangiocarcinoma (CC) is increasing, but limited data are available on predictive biomarkers of response. Human equilibrative nucleoside transporter 1 (hENT-1) is the major transporter involved in gemcitabine intracellular uptake. This...
Sparad:
I publikationen: | Oncologist |
---|---|
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
AlphaMed Press
2016
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4861359/ https://ncbi.nlm.nih.gov/pubmed/27032872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0356 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|